Close Menu

NEW YORK (GenomeWeb) – Indivumed has partnered with Singapore's Agency for Science, Technology, and Research (A*STAR) to perform proteomics research, with the aim of building out the company's IndivuType global cancer database.

According to Indivumed, IndivuType is an online resource that combines genomic, transcriptomic, proteomic, precision proteomic, and digital histopathology data with clinical information from thousands of cancer patients. It also features bioinformatic and artificial intelligence tools for data analysis.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.

Feb
20
Sponsored by
Thermo Fisher Scientific

This webinar will discuss the use of 3’ mRNA sequencing to reduce the cost of gene expression studies on Illumina NGS systems.